Arecor Therapeutics plc is a biopharmaceutical company quoted on AIM under the ticker AREC. It uses a proprietary formulation technology to develop reformulated versions of therapeutic products, with a focus on diabetes. Its lead programmes are ultra-concentrated insulins designed for automated insulin delivery systems …
TheraCryf (LSE:TCF) is an AIM-quoted biotechnology company developing medicines for neuropsychiatric conditions. Its lead asset, referred to as Ox-1, targets the orexin-1 receptor and is being developed for addiction. The company also has a dopamine transporter (DAT) modulator programme aimed at fatigue conditions and …
MedPal AI Plc (LSE:MPAL) is in sharp focus on 6 October 2026 after the shares declined 13.59%. The size of the move has pushed the stock onto investors’ watchlists as the market reassesses the latest company-specific developments, execution risks and near-term catalysts.
Cambridge Cognition Holdings plc was shown higher by 3.57% on 6 October 2026. The percentage move indicates positive market momentum during the session, but the underlying reason differs by company. In this case, the most relevant explanation is the combination of recent company-specific developments …
Crism Therapeutics Corporation was shown higher by 2.70% on 6 October 2026. The percentage move indicates positive market momentum during the session, but the underlying reason differs by company. In this case, the most relevant explanation is the combination of recent company-specific developments and …
Avacta Group PLC (LSE:AVCT) is in sharp focus on 6 October 2026 after the shares declined 6.39%. The size of the move has pushed the stock onto investors’ watchlists as the market reassesses the latest company-specific developments, execution risks and near-term catalysts.
HemoGenyx Pharmaceuticals Plc (LSE:HEMO) is in sharp focus on 6 October 2026 after the shares declined 11.00%. The size of the move has pushed the stock onto investors’ watchlists as the market reassesses the latest company-specific developments, execution risks and near-term catalysts.
Integrated Diagnostics Holdings (IDH) runs pathology laboratories, radiology services and home-visit testing, mainly in Egypt, where it operates 793 branches. It also has operations in Jordan through Biolab, in Nigeria through Echo-Lab and in Saudi Arabia, while itsBusinessin Sudan is largely closed because of …
• The latest move is being assessed against the company’s most recent operational, financial or strategic developments.
CVS Group runs veterinary practices, mainly for companion animals, in the UK and Australia, alongside related services such as laboratories, an online pharmacy and the Healthy Pet Club subscription plan. The company said it moved its listing from AIM to the Main Market of …